Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1986 Dec;70:89–103. doi: 10.1289/ehp.867089

Results of in vivo and in vitro studies for assessing prenatal toxicity

Diether Neubert, Gudrun Blankenburg, Ibrahim Chahoud, Gabriele Franz, Rainer Herken, Michael Kastner, Stephan Klug, Joachim Kröger, Ralf Krowke, Constanze Lewandowski, Hans-Joachim Merker, Thomas Schulz, Ralf Stahlmann
PMCID: PMC1474293  PMID: 3104025

Abstract

Examples of a combined approach using in vivo as well as in vitro methods for the assessment of prenatal toxicity are presented. The topics discussed include the analysis of the possible embryotoxic potential of valproic acid (VPA), female sex hormones, bis(tri-n-butyltin) oxide (TBTO), and acyclovir and the problem of supplementing in vitro systems with drug-metabolizing activity.

Full text

PDF
89

Images in this article

91FIGURE 1.
on p.91
91FIGURE 2.
on p.91
91FIGURE 3.
on p.91
92FIGURE 4.
on p.92
95FIGURE 5. A
on p.95
95FIGURE 5. B
on p.95
96FIGURE 7.
on p.96
96FIGURE 8.
on p.96
97FIGURE 9.
on p.97
99FIGURE 10.
on p.99
99FIGURE 11.
on p.99
100FIGURE 12.
on p.100
101FIGURE 13.
on p.101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrach H. J., Neubert D. Significance of organ culture techniques for evaluation of prenatal toxicity. Arch Toxicol. 1980 Sep;45(3):161–187. doi: 10.1007/BF02418996. [DOI] [PubMed] [Google Scholar]
  2. Klug S., Lewandowski C., Neubert D. Modification and standardization of the culture of early postimplantation embryos for toxicological studies. Arch Toxicol. 1985 Dec;58(2):84–88. doi: 10.1007/BF00348314. [DOI] [PubMed] [Google Scholar]
  3. Klug S., Lewandowski C., Neubert D. Modification and standardization of the culture of early postimplantation embryos for toxicological studies. Arch Toxicol. 1985 Dec;58(2):84–88. doi: 10.1007/BF00348314. [DOI] [PubMed] [Google Scholar]
  4. Krowke R., Bluth U., Neubert D. In vitro studies on the embryotoxic potential of (bis[tri-n-butyltin])oxide in a limb bud organ culture system. Arch Toxicol. 1986 Feb;58(3):125–129. doi: 10.1007/BF00340970. [DOI] [PubMed] [Google Scholar]
  5. Levy E. P., Cohen A., Fraser F. C. Hormone treatment during pregnancy and congenital heart defects. Lancet. 1973 Mar 17;1(7803):611–611. doi: 10.1016/s0140-6736(73)90762-9. [DOI] [PubMed] [Google Scholar]
  6. Manson J. M., Simons R. In vitro metabolism of cyclophosphamide in limb bud culture. Teratology. 1979 Apr;19(2):149–158. doi: 10.1002/tera.1420190204. [DOI] [PubMed] [Google Scholar]
  7. Moore H. L., Jr, Szczech G. M., Rodwell D. E., Kapp R. W., Jr, de Miranda P., Tucker W. E., Jr Preclinical toxicology studies with acyclovir: teratologic, reproductive and neonatal tests. Fundam Appl Toxicol. 1983 Nov-Dec;3(6):560–568. [PubMed] [Google Scholar]
  8. Neubert D. Benefits and limits of model systems in developmental biology and toxicology (in vitro techniques). Prog Clin Biol Res. 1985;163A:91–96. [PubMed] [Google Scholar]
  9. Neubert D., Blankenburg G., Lewandowski C., Klug S. Misinterpretations of results and creation of "artifacts" in studies on developmental toxicity using systems simpler than in vivo systems. Prog Clin Biol Res. 1985;171:241–266. [PubMed] [Google Scholar]
  10. Neubert D., Chahoud I. Significance of species and strain differences in pre- and perinatal toxicology. Acta Histochem Suppl. 1985;31:23–35. [PubMed] [Google Scholar]
  11. Neubert D., Krowke R. Effect of thalidomide-derivatives on limb development in culture. Prog Clin Biol Res. 1983;110(Pt A):387–397. [PubMed] [Google Scholar]
  12. Neubert D. The use of culture techniques in studies on prenatal toxicity. Pharmacol Ther. 1982;18(3):397–434. doi: 10.1016/0163-7258(82)90039-0. [DOI] [PubMed] [Google Scholar]
  13. Neubert D. Toxicity studies with cellular models of differentiation. Xenobiotica. 1985 Aug-Sep;15(8-9):649–660. doi: 10.3109/00498258509047423. [DOI] [PubMed] [Google Scholar]
  14. New D. A. Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol Rev Camb Philos Soc. 1978 Feb;53(1):81–122. doi: 10.1111/j.1469-185x.1978.tb00993.x. [DOI] [PubMed] [Google Scholar]
  15. Nora J. J., Nora A. H. Birth defects and oral contraceptives. Lancet. 1973 Apr 28;1(7809):941–942. doi: 10.1016/s0140-6736(73)91398-6. [DOI] [PubMed] [Google Scholar]
  16. Nora J. J., Nora A. H., Blu J., Ingram J., Fountain A., Peterson M., Lortscher R. H., Kimberling W. J. Exogenous progestogen and estrogen implicated in birth defects. JAMA. 1978 Sep 1;240(9):837–843. [PubMed] [Google Scholar]
  17. Schardein J. L. Congenital abnormalities and hormones during pregnancy: a clinical review. Teratology. 1980 Dec;22(3):251–270. doi: 10.1002/tera.1420220302. [DOI] [PubMed] [Google Scholar]
  18. Wilson J. G., Brent R. L. Are female sex hormones teratogenic? Am J Obstet Gynecol. 1981 Nov 1;141(5):567–580. doi: 10.1016/s0002-9378(15)33279-8. [DOI] [PubMed] [Google Scholar]
  19. Wiseman R. A., Dodds-Smith I. C. Cardiovascular birth defects and antenatal exposure to female sex hormones: a reevaluation of some base data. Teratology. 1984 Dec;30(3):359–370. doi: 10.1002/tera.1420300308. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES